Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Synovial Analysis Identifies Distinct Rheumatoid Arthritis Subtypes

Will Boggs MD  |  March 2, 2018

NEW YORK (Reuters Health)—Synovial gene expression and histology can be used to divide rheumatoid arthritis (RA) into high, low, and mixed inflammatory subtypes, according to results from the Accelerating Medicine Partnership: RA/SLE Network.

“The actionable implication of these findings is that it may be worth considering synovial biopsies in patients who are not responding to several of the usual immune-targeting therapies, particularly if they have low markers of inflammation in their blood,” Dr. Dana E. Orange from New York Genome Center and The Rockefeller University, New York told Reuters Health by email. “It may be that these patients also have little synovial inflammation, and immune suppression may not be useful for them.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Extensive synovial inflammation in RA can lead to joint destruction, but the classification of RA synovium is not yet included in current RA diagnostic or treatment guidelines.

Dr. Orange and colleagues used machine-learning techniques to analyze clinical, histologic, and gene-expression data from 123 RA patients and 6 osteoarthritis patients, with the aim of gaining insights into tissue inflammation and subclassification of RA. The findings were reported online February 22 in Arthritis and Rheumatology.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

They scored 20 histologic features of the synovial samples, finally settling on 10 features present in at least 5% of samples with at least fair inter-pathologist reliability.

RNA sequencing data suggested three distinct subtypes of RA synovium: low inflammatory, high inflammatory, and mixed.

Expression scores corresponding with immunity, immune-cell signaling pathways, cytokines, and chemokines increased with progression from the low- to high-inflammatory subtypes, whereas expression scores corresponding with gene sets encoding glycoproteins and protocadherins were higher in low-inflammatory and mixed subtypes than in the high-inflammatory subtype.

The high-inflammatory subtype also demonstrated high expression of both myeloid genes and lymphoid genes, whereas the low-inflammatory subtype was enriched in neuronal and TGF-beta signaling pathway genes with a paucity of inflammatory gene expression.

Histologic findings most strongly represented in the high-inflammatory subtype included three plasma-cell features: binucleate plasma cells, plasma-cell percentage, and Russell bodies.

Patients with the high-inflammatory synovial subtype had higher levels of markers of systemic inflammation and autoantibodies, and their C-reactive protein (CRP) levels correlated significantly with pain.

In contrast, patients with the low-inflammatory synovial subtype had little tissue inflammation, and their pain levels did not correlate with CRP levels.

“We were surprised to find that some patients with rheumatoid arthritis had high tender and swollen joint counts while exhibiting minimal inflammation in their tissue and normal erythrocyte sedimentation rates (ESRs) and CRPs,” Dr. Orange said. “One interpretation of this result is that these patients may have developed osteoarthritis in the joint that we evaluated and have active rheumatoid arthritis in their other joints. However, the discrepancy between high joint counts and normal acute-phase reactants raises the question of whether any of their other joints were highly inflamed.”

Page: 1 2 | Single Page
Share: 

Filed under:Rheumatoid Arthritis Tagged with:Accelerating Medicine Partnership: RA/SLE NetworkDana E. Orangeimmune suppressionRheumatoid Arthritis (RA)rheumatoid arthritis subtypessynovial analysissynovial biopsiessynovial gene expression

Related Articles

    Study Finds Correlations Between Synovial Tissue & Gene Expression

    October 18, 2018

    Rheumatoid arthritis (RA) can be typed, grouped and categorized in different ways, and subgroup identification could help guide future research and treatment strategies based on which subtypes respond to which treatment. A new study explored an approach associating gene expression profiling with histologic analysis of synovium samples to define RA subtypes and then examined how…

    Doest Rheumatoid Arthritis Take a Toll?

    November 15, 2013

    Exploring the Toll background

    Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis

    July 11, 2016

    Understanding how human leukocyte antigen (HLA) class I molecule B27 promotes spondyloarthritis has intrigued researchers for four decades. Although the association between the single gene variant HLA-B27—specifically some of its subtypes—with ankylosing spondylitis (AS) is particularly strong, how HLA-B27 directly influences disease development has not yet been clearly explained, although hypotheses continue to be generated….

    Alpha Tauri 3D Graphics / shutterstock.com

    Study Elucidates Potential Flare Pathways in Rheumatoid Arthritis

    December 14, 2020

    Research in The New England Journal of Medicine has opened new avenues for exploring the pathophysiology of disease flares in rheumatoid arthritis.1 Through longitudinal genomic analysis, researchers have identified a naive B cell signature prior to rheumatoid arthritis flares, as well as a type of mesenchymal cell, that may play an important role in flare…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences